First international conference on developmental, translational and clinical pharmacogenomics

NewsGuard 100/100 Score

University of South Florida College of Pharmacy hosts conference Sept. 22-24

The first international conference hosted by the University of South Florida College of Pharmacy will focus on ways to improve health care by customizing drug prescribing and treatment based on an individual's genetic makeup.

The 1st Annual International Conference on Developmental, Translational and Clinical Pharmacogenomics will be held Sept. 22 to 24 at the Dr. Kiran C. Patel Center for Global Health Solutions at the USF Tampa campus, 4202 E. Fowler Avenue. Tampa, FL.

World-renowned scientists from the United States, China, India, Brazil, Canada and other countries will gather for the conference, which is sponsored by the USF College of Pharmacy, USF Health, and the Ibero-American Science & Technology Consortium. Attendees will have the opportunity to learn about the latest in personalized medicine and pharmacogenomics, the study of how genetic variation among individuals contributes to differences in the way people respond to medicines.

While still in its infancy, the field of pharmacogenomics holds promise for the development of drugs customized to more effectively and safely treat a wide range of conditions, including cardiovascular disease, Alzheimer's disease, cancer, HIV/AIDS and asthma.

Conference speakers and topics will include:

  • Mark Ratain, MD, associate director of clinical sciences at the University of Chicago's Cancer Research Center, "Pharmacogenetics in Oncology."
  • Lin He, PhD, dean of the Institute of Biomedical Sciences, Fudan University, Shanghai, China, "Genes, Diseases & Drug Therapy."
  • Kelan Tantisira, MD, MPH, assistant professor of medicine, Harvard Medical School, "Pharmacogenetics in Asthma Treatment."
  • Katherine Kolor, PhD, policy officer, National Office of Public Health Genomics, Centers for Disease Control and Prevention, "Translation of Genomic Tests."
  • Julie Johnson, PharmD, professor of cardiovascular medicine, University of Florida Colleges of Pharmacy & Medicine, director of UF Center for Pharmacogenomics, "Cardiovascular Pharmacogenetics and Individualized Drug Therapy."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New trials show promise for immune checkpoint blockers in early-stage lung cancer